Attovia Therapeutics, Inc. (ATTO) vs Geron Corporation (GERN)
A side-by-side comparison of Attovia Therapeutics, Inc. and Geron Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ATTO
Attovia Therapeutics, Inc.
$17.71HealthcareDelayed quote: Oct 6, 2026, 10:05 AM EDT
GERN
Geron Corporation
$1.21HealthcareDelayed quote: Oct 6, 2026, 10:05 AM EDT
Total return — ATTO vs GERN
growth of $100 · dividends reinvested · last 1yATTO -17.8% (-17.8%/yr)GERN -16.6% (-16.6%/yr)GERN compounded faster over this window
ATTO GERN
ATTO vs GERN: by the numbers
- •GERN is the larger company ($773M vs $762M market cap).
- •Both run net losses; GERN's is the smaller (-34.17% vs -4490.89% net margin).
Metrics side by side
Valuation
| Metric | ATTO | GERN |
|---|---|---|
| P/S ratio | N/A | 3.78 |
| P/B ratio | N/A | 3.54 |
Profitability
| Metric | ATTO | GERN |
|---|---|---|
| Gross margin | 40.44% | 97.42% |
| Operating margin | -4974.74% | -29.28% |
| Net margin | -4490.89% | -34.17% |
| ROE | -40.21% | -31.97% |
| ROIC | -42.83% | -8.34% |
Growth (annualized)
| Metric | ATTO | GERN |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 247.85% |
| Total return CAGR (5Y) | N/A | -1.87% |
Go deeper
Dig into the metrics
Attovia Therapeutics ROEGeron ROEAttovia Therapeutics operating marginGeron operating marginAttovia Therapeutics revenue growthGeron revenue growthAttovia Therapeutics free cash flowGeron free cash flow
Attovia Therapeutics & Geron appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.